𝔖 Bobbio Scriptorium
✦   LIBER   ✦

LRRK2 in Parkinson’s disease: in vivo models and approaches for understanding pathogenic roles

✍ Scribed by Zhenyu Yue

Book ID
111313215
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
216 KB
Volume
276
Category
Article
ISSN
1432-1327

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Novel pathogenic LRRK2 p.Asn1437His subs
Novel pathogenic LRRK2 p.Asn1437His substitution in familial Parkinson's disease
✍ Jan O. Aasly; Carles Vilariño-Güell; Justus C. Dachsel; Philip J. Webber; Andrew 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 608 KB

## Abstract Genealogical investigation of a large Norwegian family (F04) with autosomal dominant parkinsonism has identified 18 affected family members over four generations. Genetic studies have revealed a novel pathogenic __LRRK2__ mutation c.4309 A>C (p.Asn1437His) that co‐segregates with diseas

R1514Q substitution in Lrrk2 is not a pa
R1514Q substitution in Lrrk2 is not a pathogenic Parkinson's disease mutation
✍ William C. Nichols; Diane K. Marek; Michael W. Pauciulo; Nathan Pankratz; Cheryl 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

## Abstract Mutations in __LRRK2__ were first reported as causing Parkinson's disease (PD) in late 2004. Since then, approximately a dozen __LRRK2__ substitutions have been identified that are believed to be pathogenic mutations. The substitution of adenine for guanine at nucleotide 4541 (4541G>A)